Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery

The number of agents that are potentially effective in the adjuvant treatment of locally advanced resectable colon cancer is increasing. Consequently, it is important to ascertain which subgroups of patients will benefit from a specific treatment. Despite more than two decades of research into the m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tejpar, Sabine, Bertagnolli, Monica, Bosman, Fred, Lenz, Heinz-Joseph, Garraway, Levi, Waldman, Frederic, Warren, Robert, Bild, Andrea, Collins-Brennan, Denise, Hahn, Hejin, Harkin, D. Paul, Kennedy, Richard, Ilyas, Mohammad, Morreau, Hans, Proutski, Vitali, Swanton, Charles, Tomlinson, Ian, Delorenzi, Mauro, Fiocca, Roberto, Van Cutsem, Eric, Roth, Arnaud
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2010
Gaiak:
Academia-Pharma Intersect
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227961/
https://ncbi.nlm.nih.gov/pubmed/20350999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0233
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak